Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction.
cellular microenvironment
chronic lymphocytic leukaemia (CLL)
cytokines profiles
immune dysfunction
soluble immune checkpoints
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
06
2022
accepted:
24
08
2022
entrez:
17
10
2022
pubmed:
18
10
2022
medline:
19
10
2022
Statut:
epublish
Résumé
Chronic lymphocytic leukemia (CLL) is a lymphoid neoplasm characterized by the accumulation of mature B cells. The diagnosis is established by the detection of monoclonal B lymphocytes in peripheral blood, even in early stages [monoclonal B-cell lymphocytosis (MBL
Identifiants
pubmed: 36248816
doi: 10.3389/fimmu.2022.965905
pmc: PMC9554405
doi:
Substances chimiques
Biomarkers
0
Chemokine CXCL10
0
Immunoglobulin Heavy Chains
0
Immunologic Factors
0
Interleukin-4
207137-56-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
965905Informations de copyright
Copyright © 2022 Landeira-Viñuela, Arias-Hidalgo, Juanes-Velasco, Alcoceba, Navarro-Bailón, Pedreira, Lecrevisse, Díaz-Muñoz, Sánchez-Santos, Hernández, García-Vaquero, Góngora, De Las Rivas, González, Orfao and Fuentes.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Mol Pharm. 2022 May 2;19(5):1273-1293
pubmed: 35436123
Nat Rev Cancer. 2019 Mar;19(3):162-175
pubmed: 30696923
Signal Transduct Target Ther. 2020 Oct 29;5(1):250
pubmed: 33122640
Int J Mol Sci. 2018 Jan 13;19(1):
pubmed: 29342882
Leukemia. 2010 Jun;24(6):1152-9
pubmed: 20428196
Blood. 2013 Oct 24;122(17):3010-9
pubmed: 24014238
Front Immunol. 2018 Nov 26;9:2720
pubmed: 30542344
Cancers (Basel). 2020 Jul 04;12(7):
pubmed: 32635472
Cells. 2021 Jan 22;10(2):
pubmed: 33499012
Eur J Immunol. 2017 May;47(5):765-779
pubmed: 28393361
J Bioinform Comput Biol. 2005 Apr;3(2):185-205
pubmed: 15852500
Life Sci. 2021 May 15;273:119150
pubmed: 33662426
Oncol Lett. 2018 Feb;15(2):1580-1590
pubmed: 29434853
Cancers (Basel). 2021 Jul 30;13(15):
pubmed: 34359757
Front Oncol. 2020 Aug 19;10:1422
pubmed: 32974152
Cancer Sci. 2015 Sep;106(9):1103-10
pubmed: 26132605
Nat Rev Dis Primers. 2017 Jan 19;3:16096
pubmed: 28102226
Blood. 2018 Jun 21;131(25):2745-2760
pubmed: 29540348
Cancer. 1981 Jul 1;48(1):198-206
pubmed: 7237385
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Blood. 1975 Aug;46(2):219-34
pubmed: 1139039
J Cell Physiol. 2020 Dec;235(12):9424-9431
pubmed: 32383245
J Immunol Res. 2020 Nov 18;2020:8820377
pubmed: 33294467
Eur J Immunol. 2001 May;31(5):1428-37
pubmed: 11465099
Sci Rep. 2020 Feb 25;10(1):3392
pubmed: 32099055
Clin Immunol. 2019 Jul;204:64-68
pubmed: 30366105
Front Immunol. 2020 Apr 02;11:537
pubmed: 32300343
Adv Exp Med Biol. 2020;1231:45-51
pubmed: 32060845
J Immunother Cancer. 2021 Feb;9(2):
pubmed: 33637602
Cancers (Basel). 2021 Apr 27;13(9):
pubmed: 33925565
Cancers (Basel). 2020 Sep 05;12(9):
pubmed: 32899476
Clin Immunol. 2016 Mar;164:10-20
pubmed: 26794910
Int J Cancer. 2016 May 15;138(10):2357-67
pubmed: 26684261
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1226-38
pubmed: 16119262
Front Med (Lausanne). 2019 May 29;6:119
pubmed: 31192215
Cell Death Dis. 2018 Nov 26;9(12):1160
pubmed: 30478302
Immunobiology. 2019 Sep;224(5):649-658
pubmed: 31421859
Cancers (Basel). 2020 Feb 24;12(2):
pubmed: 32102441
Cancer Immunol Res. 2018 Feb;6(2):209-221
pubmed: 29321210
Exp Hematol. 2018 Apr;60:47-56.e1
pubmed: 29353075
PLoS Comput Biol. 2018 Jan 29;14(1):e1005968
pubmed: 29377902
Front Immunol. 2020 May 15;11:938
pubmed: 32499785